TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES
D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 53-53